Literature DB >> 21971556

Temporal assessment of ribose treatment on self-assembled articular cartilage constructs.

Sriram V Eleswarapu1, Justin A Chen, Kyriacos A Athanasiou.   

Abstract

Articular cartilage cannot repair itself in response to degradation from injury or osteoarthritis. As such, there is a substantial clinical need for replacements of damaged cartilage. Tissue engineering aims to fulfill this need by developing replacement tissues in vitro. A major goal of cartilage tissue engineering is to produce tissues with robust biochemical and biomechanical properties. One technique that has been proposed to improve these properties in engineered tissue is the use of non-enzymatic glycation to induce collagen crosslinking, an attractive solution that may avoid the risks of cytotoxicity posed by conventional crosslinking agents such as glutaraldehyde. The objectives of this study were (1) to determine whether continuous application of ribose would enhance biochemical and biomechanical properties of self-assembled articular cartilage constructs, and (2) to identify an optimal time window for continuous ribose treatment. Self-assembled constructs were grown for 4 weeks using a previously established method and were subjected to continuous 7-day treatment with 30 mM ribose during culture weeks 1, 2, 3, or 4, or for the entire 4-week culture. Control constructs were grown in parallel, and all groups were evaluated for gross morphology, histology, cellularity, collagen and sulfated glycosaminoglycan (GAG) content, and compressive and tensile mechanical properties. Compared to control constructs, it was found that treatment with ribose during week 2 and for the entire duration of culture resulted in significant 62% and 40% increases in compressive stiffness, respectively; significant 66% and 44% increases in tensile stiffness; and significant 50% and 126% increases in tensile strength. Similar statistically significant trends were observed for collagen and GAG. In contrast, constructs treated with ribose during week 1 had poorer biochemical and biomechanical properties, although they were significantly larger and more cellular than all other groups. We conclude that non-enzymatic glycation with ribose is an effective method for improving tissue engineered cartilage and that specific temporal intervention windows exist to achieve optimal functional properties.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971556      PMCID: PMC3200502          DOI: 10.1016/j.bbrc.2011.09.107

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Functional tissue engineering: the role of biomechanics.

Authors:  D L Butler; S A Goldstein; F Guilak
Journal:  J Biomech Eng       Date:  2000-12       Impact factor: 2.097

2.  BENEFICIAL EFFECTS OF EXOGENOUS CROSSLINKING AGENTS ON SELF-ASSEMBLED TISSUE ENGINEERED CARTILAGE CONSTRUCT BIOMECHANICAL PROPERTIES.

Authors:  Benjamin D Elder; Arvind Mohan; Kyriacos A Athanasiou
Journal:  J Mech Med Biol       Date:  2011-04       Impact factor: 0.897

Review 3.  Divide, accumulate, differentiate: cell condensation in skeletal development revisited.

Authors:  B K Hall; T Miyake
Journal:  Int J Dev Biol       Date:  1995-12       Impact factor: 2.203

4.  Non-enzymatic glycation of chondrocyte-seeded collagen gels for cartilage tissue engineering.

Authors:  Rani Roy; Adele L Boskey; Lawrence J Bonassar
Journal:  J Orthop Res       Date:  2008-11       Impact factor: 3.494

5.  Intracellular Na(+) and Ca(2+) modulation increases the tensile properties of developing engineered articular cartilage.

Authors:  Roman M Natoli; Stacey Skaalure; Shweta Bijlani; Ke X Chen; Jerry Hu; Kyriacos A Athanasiou
Journal:  Arthritis Rheum       Date:  2010-04

6.  Accelerated age-related browning of human collagen in diabetes mellitus.

Authors:  V M Monnier; R R Kohn; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 7.  Collagens of articular cartilage: structure, function, and importance in tissue engineering.

Authors:  Donald J Responte; Roman M Natoli; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2007

8.  Chondroitinase ABC treatment results in greater tensile properties of self-assembled tissue-engineered articular cartilage.

Authors:  Roman M Natoli; Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

9.  Effects of temporal hydrostatic pressure on tissue-engineered bovine articular cartilage constructs.

Authors:  Benjamin D Elder; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

10.  Matrix development in self-assembly of articular cartilage.

Authors:  Gidon Ofek; Christopher M Revell; Jerry C Hu; David D Allison; K Jane Grande-Allen; Kyriacos A Athanasiou
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  4 in total

1.  Tissue-engineered articular cartilage exhibits tension-compression nonlinearity reminiscent of the native cartilage.

Authors:  Terri-Ann N Kelly; Brendan L Roach; Zachary D Weidner; Charles R Mackenzie-Smith; Grace D O'Connell; Eric G Lima; Aaron M Stoker; James L Cook; Gerard A Ateshian; Clark T Hung
Journal:  J Biomech       Date:  2013-06-21       Impact factor: 2.712

2.  Enhancing the mechanical properties of engineered tissue through matrix remodeling via the signaling phospholipid lysophosphatidic acid.

Authors:  Pasha Hadidi; Kyriacos A Athanasiou
Journal:  Biochem Biophys Res Commun       Date:  2013-02-28       Impact factor: 3.575

3.  TRPV4 channel activation improves the tensile properties of self-assembled articular cartilage constructs.

Authors:  Sriram V Eleswarapu; Kyriacos A Athanasiou
Journal:  Acta Biomater       Date:  2012-11-02       Impact factor: 8.947

4.  Induced collagen cross-links enhance cartilage integration.

Authors:  Aristos A Athens; Eleftherios A Makris; Jerry C Hu
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.